High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination
Oncology/Hematology > Myeloma — ORR of 80% at recommended dose of talquetamab, teclistamab but with high rates of grade 3/4...
Oncology/Hematology > Myeloma — ORR of 80% at recommended dose of talquetamab, teclistamab but with high rates of grade 3/4...